24 March 2020

The biotechnology company focused on developing curative gene therapies for chronic systemic diseases has announced the appointment of Julie Krop M.D. as Chief Medical Officer (CMO) with effect from 1st April 2020.

For further information, visit the Freeline Therapeutics website.